Evidence map›Paper›PMID 41986877›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2026

IL-33 promotes transcriptional and metabolic adaptations of tissue-resident Th2 cells.

Anna K Kania, David E Sanin, Xinyue Gu, Mia Gidley, Eryk Kokosinski, Allen Smith, Erika Pearce, Edward J Pearce

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Anna K KaniaDepartment of Oncology, Bloomberg Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, United States.ORCID 0000-0002-5819-5694
David E SaninDepartment of Oncology, Bloomberg Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Xinyue GuDepartment of Oncology, Bloomberg Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Mia GidleyDepartment of Oncology, Bloomberg Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Eryk KokosinskiDepartment of Oncology, Bloomberg Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Allen SmithUSDA, Beltsville Human Nutrition Research Center and Diet, Genomics, and Immunology Laboratory, Beltsville, MD, United States.
Erika PearceDepartment of Oncology, Bloomberg Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Edward J PearceDepartment of Oncology, Bloomberg Kimmel Institute of Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, United States.ORCID 0000-0003-1001-9656

Funding

Stromal cells in immunity to infectionR01AI177287 · NIAID · JOHNS HOPKINS UNIVERSITY · PI EDWARD J. PEARCE · 2023 to 2026
$2.3M
Mitochondrial Membrane Dynamics in Th17 CellsR01AI172832 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Erika L Pearce · 2023 to 2026
$2.3M
Maryland Cancer Moonshot Research Grant to the Johns Hopkins Medical InstitutionsNIH HHS R01AI172832NIH HHS R01AI177287
6 · The paper itself

Abstract

The polarization of naive CD4+ T cells into Th2 cells is initiated in lymphoid organs and completed as the cells become tissue resident, where they express ST2, the receptor for the alarmin interleukin (IL)-33, which may be a key signal for tissue integration. Cellular metabolic requirements associated with this transition remain poorly understood. To address this, we compared the response of lymphoid tissue (LT) Th2 cells from helminth parasite-infected mice to stimulation by IL-33 versus through the T cell receptor via anti-CD3/CD28. We found that IL-33, but not anti-CD3/CD28, induced the development of tissue-resident like Th2 cells expressing ST2. This was associated with IL-33 induced changes in arginine metabolism linked to mTORC1 activation and polyamine synthesis, which were required for the development of tissue-resident like Th2 cells. Furthermore, IL-33 induced transcriptional changes in genes involved in chemotaxis and cell adhesion that may be critical for tissue integration. Our findings provide insights into adaptations of Th2 cells responding to tissue-integration cues and more broadly support the view that IL-33 promotes the expression of the transcriptional program associated with tissue residency of GATA3-expressing cells in adipose and possibly other tissues.

Indexed as

Interleukin-33Th2 CellsAnimalsInterleukin-1 Receptor-Like 1 ProteinLymphoid TissueMiceMice, Inbred C57BLTranscription, GeneticIl1rl1 protein, mouseIl33 protein, mouseInterleukin-1 Receptor-Like 1 ProteinInterleukin-33IL33Th2 cellstissue residency

Identifiers

PMID41986877
PMCPMC13082907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.